DeSimone Jill

SEC Form 4 insider trading activity

DeSimone Jill has filed 2 SEC Form 4 filings (15 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Jun 26, 2026.

On the most recent filing, DeSimone Jill is listed as Director at Praxis Precision Medicines, Inc. Inside the rolling window, DeSimone Jill reported no open-market purchases and 1 open-market sale totaling $3.6M in PRAX.

Companies traded

Other insiders at PRAX

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$3.6M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
PRAX
DeSimone Jill
Sale$3.6MJun 26SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has DeSimone Jill made?

DeSimone Jill has filed 2 SEC Form 4 filings (15 transaction rows) across 1 company since 2026.

Which companies does DeSimone Jill trade?

DeSimone Jill has filed SEC Form 4 disclosures for 1 company, including PRAX.

When was DeSimone Jill's most recent SEC Form 4 filing?

DeSimone Jill's most recent SEC Form 4 filing on Tracefour is dated Jun 26, 2026.

What is DeSimone Jill's total buy and sell value in the current window?

Inside the rolling retention window, DeSimone Jill bought $0 and sold $3.6M based on SEC Form 4 filings.

What was DeSimone Jill's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 11,600 PRAX shares on 2026-06-24, worth $3.6M, per SEC Form 4 filings.